Schizophrenia Clinical Trial
Official title:
Perspectives on the INternational CLassification of Diseases (11th Revision)Íž Using Lived Experience to Improve Mental Health Diagnosis in NHS England: INCLUDE Study
The focus of this study is not about what it is like to have a mental disorder, but instead
the diagnostic experience.
Some people find diagnoses helpful, but some find them upsetting and harmful. Research is
therefore needed to improve diagnostic processes. It has been suggested that patient
experiences and outcomes may be affected by the diagnostic tools used, including diagnostic
criteria, labels and language. In the NHS, the tool used by doctors to help diagnose people
is a guidebook called the International Classification of Diseases (ICD). A new version of
this guide is due to be released in 2018.
This project will use focus groups to ask people who use mental health services and
diagnosing doctors in those services what they think about the labels and language in the new
guide. The investigators can then suggest changes before the guide is published. The
investigators hope that this research will improve mental health diagnosis. The research will
take place in Norfolk and Suffolk and span eight months.
This is a qualitative project requested by the World Health Organisation (WHO), and planned
by Norfolk and Suffolk NHS Foundation Trust and the University of East Anglia. The research
aims and design have been developed in consultation with service users, clinicians, academics
and the World Health Organisation (WHO). These groups have told the investigators that mental
health diagnosis can have unintended, negative consequences. This is supported by a large
body of existing research. It has been suggested that patient experiences and outcomes may be
affected by the diagnostic classifications used (i.e. labels and language). The investigators
plan to explore service users' and clinicians' views on the proposed ICD-11 diagnostic
classifications. To do this, the investigators will provide participants with the proposed
ICD-11 diagnostic classification relevant to their experience, and conduct focus groups to
explore people's views of the new diagnostic classifications, including judgement about the
clinical accuracy, the language used, what people think is helpful and unhelpful, and what
could be improved. The topic guide for the focus groups will be developed in consultation
with the advisory group (comprising service users, carers and clinicians).
The investigators will conduct separate focus groups for service users and clinicians as the
investigators believe joint groups may impact the findings. The investigators will collate
findings to produce recommendations for the criteria and language proposed for ICD-11. These
recommendations will be discussed in feedback groups of service users, carers and clinicians,
which will provide further participants an opportunity for additional thoughts and
reflection.
Inclusion
- Adult service users will have formally received one of the five diagnoses under
investigation: Unipolar Depression,Schizophrenia, Bipolar Disorder, Generalised Anxiety
Disorder or Personality Disorder.
- Individuals will be excluded if their participation is deemed unsafe to themselves or
others by their clinical team or clinicians on the research team.
- Clinicians will have had experience working with mental health, either as a GP or
psychiatrist, where diagnosing one of the above five diagnoses is part of their role.
- Carers will have had experience looking after someone diagnosed with one of the five
diagnoses mentioned above.
- Participants who have been involved in one aspect of the study will be excluded from
taking part in any other aspects (e.g. participants in the focus group may not be
involved in other focus or feedback groups).
- Participants with multiple diagnoses will only be allowed to attend one focus group, but
they may choose which one of the relevant focus groups they would like to take part in.
Exclusion:
- Non-English speakers will not be included in the study.
- Individuals under 18 years old will be excluded.
- Individuals who do not have capacity to give consent will be excluded. Individuals who
lose capacity at any point between referral and the end of their participation will be
removed from the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |